A high proportion of prostate cancer patients have their care pathways changed after being scanned with PET/CT enhanced by the injected radiotracer gallium-68 (Ga-68) and prostate-specific membrane antigen (PSMA).
Implementing structured reporting templates has helped an academic radiology department increase its collective use of the clear and definitive term normal. However, use of the fuzzier term unremarkable also went up, suggesting more training may be in order.
Practical and noninvasive, MRI with arterial spin labeling may substitute for PET-CT with the radiotracer 18FDG, which requires intravenous injection, for imaging the brains of patients with suspected early-stage dementia.
U.S. healthcare is in for a wave of technology-driven disruption over the next five years unlike any it’s seen up to now—and it’s up to imaging professionals to light the way in figuring out what to embrace, what to reject and what to take a chance on.